BARDA DRIVe ImmuneChip+ (through
Supports creators of immune-enabled organ-on-chip systems and biosensing manufacturing for critical health technology challenges.
The BARDA DRIVe ImmuneChip+ program is an open Broad Agency Announcement (BAA) administered by the Biomedical Advanced Research and Development Authority's Division of Research, Innovation, and Ventures, accepting proposals on a rolling basis through September 28, 2028. The program funds advanced in vitro microphysiological systems — commonly known as organ-on-chip platforms — that incorporate imm…
Advanced in vitro microphysiological systems incorporating immune components — including organ-on-chip platforms with automated manufacturing, biosensors, and multi-tissue integration — for CBRN medical countermeasure development.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see the timeline